<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dev Immunol</journal-id><journal-title>Developmental Immunology</journal-title><issn pub-type="ppub">1044-6672</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pii">S1740252297692707</article-id><article-id pub-id-type="doi">10.1155/1997/69270</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A Comparative Analysis of the Murine Thymic Microenvironment in Normal, Autoimmune, and Immunodeficiency States</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Takeoka</surname><given-names>Yuichi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Shao-Yuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Boyd</surname><given-names>Richard L.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Tsuneyama</surname><given-names>Koichi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Taguchi</surname><given-names>Nobuhisa</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Morita</surname><given-names>Shinji</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yago</surname><given-names>Hisashi</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Suehiro</surname><given-names>Seishi</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ansari</surname><given-names>Aftab A.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Shultz</surname><given-names>Leonard D.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gershwin</surname><given-names>M. Eric </given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Division of Rheumatology</addr-line><addr-line>Allergy and Clinical Immunology</addr-line><addr-line>University of California at Davis</addr-line><addr-line>School of Medicine</addr-line><addr-line>Davis</addr-line><addr-line>California</addr-line><addr-line>95616</addr-line><country>USA</country></aff><aff id="aff2"><label>2</label><addr-line>Institute of Bio-Active Science</addr-line><addr-line>Nippon Zoki Pharmaceutical Co. Ltd.</addr-line><addr-line>Yashiro</addr-line><addr-line>Hyogo</addr-line><addr-line>673-14</addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><addr-line>Department of Pathology and Immunology</addr-line><addr-line>Monash University</addr-line><addr-line>Prahran</addr-line><addr-line>Victoria</addr-line><addr-line>3181</addr-line><country>Australia</country></aff><aff id="aff4"><label>4</label><addr-line>Department of Pathology</addr-line><addr-line>Emory University</addr-line><addr-line>School of Medicine</addr-line><addr-line>Atlanta</addr-line><addr-line>Georgia</addr-line><addr-line>30322</addr-line><country>USA</country></aff><aff id="aff5"><label>5</label><addr-line>Jackson Laboratory</addr-line><addr-line>Bar Harbor</addr-line><addr-line>Maine</addr-line><addr-line>04609</addr-line><country>USA</country></aff><aff id="aff6"><label>6</label><addr-line>Department of Pathology</addr-line><addr-line>Toyama City Hospital</addr-line><addr-line>Imaizumi</addr-line><addr-line>Toyama</addr-line><addr-line>939</addr-line><country>Japan</country></aff><pub-date pub-type="ppub"><year>1997</year></pub-date><volume>5</volume><issue>2</issue><fpage>79</fpage><lpage>89</lpage><history><date date-type="received"><day>14</day><month>10</month><year>1996</year></date><date date-type="accepted"><day>10</day><month>12</month><year>1996</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 1997 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1997</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>It is widely accepted that the thymic microenvironment regulates normal thymopoiesis through a highly coordinated and complex series of cellular and cytokine interactions. A direct corollary of this is that abnormalities within the microenvironment could be of etiologic significance in T-cell-based diseases. Our laboratory has developed a large panel of monoclonal antibodies (mAbs) that react specifically with epithelial or nonepithelial markers in the thymus. We have taken advantage of these reagents to characterize the thymic microenvironment of several genetic strains of mice, including BALB/cJ, C57BL/6J, NZB/BlnJ, SM/J, NOD/Ltz, NOD/Ltz-<italic>scid/sz</italic>, C57BL/6J-<italic>Hcph</italic> m<sup>e</sup>/<italic>Hcph</italic> m<sup>e</sup>, and ALY/NscJcl-<italic>aly/aly</italic> mice, and littermate control animals. We report herein that control mice, including strains of several backgrounds, have a very consistent phenotypic profile with this panel of monoclonal antibodies, including reactivity with thymic epithelial cells in the cortex, the medulla and the corticomedullary junction, and the extracellular matrix. In contrast, the disease-prone strains studied have unique, abnormal staining of thymic cortex and medulla at both the structural and cellular levels. These phenotypic data suggest that abnormalities in interactions between developing thymocytes and stromal cells characterize disease-prone mice.</p></abstract><kwd-group><kwd>Thymic microenvironment</kwd><kwd>NZB mouse</kwd><kwd>SM/J mouse</kwd><kwd>NOD mouse</kwd><kwd>NOD-scib mouse</kwd><kwd>Aly/aly mouse</kwd><kwd>Motheaten (Hpch^me/Hpch^me) mouse</kwd></kwd-group></article-meta></front></article> 